1
3rd Quarter 2009 Financial Highlights October 29, 2009
2
Forward-looking statements
This presentation includes forward-looking statements that are subject to risks and uncertainties, including those pertaining to the anticipated benefits to be realized from the proposals described herein. This presentation contains a number of forward-looking statements including, in particular, statements about future events, future financial performance, plans, strategies, expectations, prospects, competitive environment, regulation and supply and demand. BASF has based these forward-looking statements on its views with respect to future events and financial performance. Actual financial performance of the entities described herein could differ materially from that projected in the forward-looking statements due to the inherent uncertainty of estimates, forecasts and projections, and financial performance may be better or worse than anticipated. Given these uncertainties, readers should not put undue reliance on any forward-looking statements.
Forward-looking statements represent estimates and assumptions only as of the date that they were made. The information contained in this presentation is subject to change without notice and BASF does not undertake any duty to update the forward-looking statements, and the estimates and assumptions associated with them, except to the extent required by applicable laws and regulations.
3
1 | Business review2 | Operational excellence at work3 | Outlook
4
Further improved performance due to operational strength
• Destocking has come to an end• Asia pushed by economic recovery – in particular China• Successful value before volume strategy• Cost-cutting and efficiency improvements compensating volume decline
Accelerated Ciba integration
Business development Q3 2009
Key figures Q3 2009 vs. Q3 2008• Sales: €12.8 billion (-19%)• EBITDA: €2.0 billion (-8%)• EBIT before special items: €1.2 billion (-20%)• Net income: €237 million (-69%)• Earnings per share: €0.26 (-68%)
Adjusted EPS: €0.61 (-36%)• Operating cash flow 1-9’09: €5.4 billion (+50%)
5
In billion €
Cash provided by operating activities Free cash flow** Cash provided by operating activities
less capex (in 2005 before CTA)** According to German GAAP
Strong cash flow generation
• Operating cash flow in1-9’09: €5.4 billion (€1.7 billion in Q3’09)
• Significant reduction of net working capital in1-9'09: €2.0 billion(~€450 million in Q3'09)
• Cash used in investing activities 1-9'09:€3.4 billion
• CAPEX 1-9'09: €1.8 billion
• Net debt reduction in Q3'09: €1.4 billion
-1
0
1
2
3
4
5
6
2001** 2002** 2003** 2004 2005* 2006 2007 2008 1-92009
5.4
3.5
6
-45%
-40%
-35%
-30%
-25%
-20%
-15%
-10%
-5%
0%
Chemical Activities* Quarterly development net sales to third parties
* Without Crop Protection, Oil & Gas and Ciba; Europe and South America in Euro; North America and Asia Pacific in US Dollar
Eu
Q4'08 Q1'09 Q2'09 Q3'09
Eu
Eu
EuNA
NA
NA
NA
Baseline: average sales in 2008• Slump in North America
(NA) more pronounced than in Europe (Eu)
7
-45%
-40%
-35%
-30%
-25%
-20%
-15%
-10%
-5%
0%
Chemical Activities* Quarterly development net sales to third parties
* Without Crop Protection, Oil & Gas and Ciba; Europe and South America in Euro; North America and Asia Pacific in US Dollar
Eu
Q4'08 Q1'09 Q2'09 Q3'09
Eu
Eu
EuNA
NA
NA
NA
Baseline: average sales in 2008
AP
AP
AP
AP
• Slump in North America (NA) more pronounced than in Europe (Eu)
• Asia Pacific (AP) recovering rapidly
8
-45%
-40%
-35%
-30%
-25%
-20%
-15%
-10%
-5%
0%
Chemical Activities* Quarterly development net sales to third parties
• Slump in North America (NA) more pronounced than in Europe (Eu)
• Asia Pacific (AP) recovering rapidly
• Trough in South America (SA) not as deep as in the rest of the world
* Without Crop Protection, Oil & Gas and Ciba; Europe and South America in Euro; North America and Asia Pacific in US Dollar
Eu
Q4'08 Q1'09 Q2'09 Q3'09
Eu
EuNA
NA
NA
NA
Baseline: average sales in 2008
AP
AP
AP
AP
SA
SA
SA
Eu
SA
9
Volumes Portfolio
Q2
+11
Currencies
Q3
+13
Q4
–3
2008
Components of sales developmentChange in % vs. equivalent period of previous year
-8
15
5
-1
17
1
-52
7
-13
1
Q1
–23
-20
2
Prices
2009
-5-13
35
-18
Q2
–23
Q3
–19
-19
15
-6
Sequential comparisonQ3'09 vs. Q2'09
BASF Group:• Volume: +3%• Prices: 0%• Portfolio: +1%• Currencies: –1%
Chemical Activities:• Volume: +8%• Price: +4%
Oil & Gas: • Volume: +9%• Price: –15%
Decline in demand softened, but increasing pressure on prices
10
Chemicals Q3 vs. Q2'09Sales and EBIT before special items, in million €
EBIT before special items
• Q3'09 vs. Q2'09: Volumes +4%, prices +9%, portfolio 0%, currencies –3%[Q3'09 vs. Q3'08: Volumes –11%, prices –24%, portfolio 0%, currencies +1%]
• Improved earnings in all divisions due to cost cutting and value over volume strategy• Petrochemicals: demand and pricing positively impacted by temporary shortages for
olefins and acrylic derivatives; higher raw material costs successfully passed on.• Inorganics and Intermediates: Higher demand from key customer industries like
electronics, textile, coatings and plastics.
401
104 84
258364
0
100
200
300
400
Q32008
Q42008
Q12009
Q22009
Q32009
Petrochemicals+10%
Inorganics+11%
Intermediates+12%
Total sales: €2,000 million: +10.6%
262500
1,238
11
Plastics Q3 vs. Q2'09Sales and EBIT before special items, in million €
• Q3'09 vs. Q2'09: Volumes +10%, prices +5%, portfolio 0%, currencies –3%[Q3'09 vs. Q3'08: Volumes –4%, prices –18%, portfolio 0%, currencies +2%]
• Considerable earnings improvement driven by cost cutting and price/margin management.• Performance Polymers: strong growth driven by Engineering Plastics. Higher prices for
polyamides, intermediates and foams.• Polyurethanes: stronger demand for MDI and TDI in all regions, especially Asia; global
margin improvements for TDI.
Polyurethanes+12%
PerformancePolymers+12%
Total sales: €1,967 million: +12% EBIT before special items
198
-282
138216
-29
-300-200-100
0100200300
Q32008
Q12009
Q22009
Q32009
843
1,124
Q32008
Q42008
Q12009
Q22009
Q32009
12
Performance Products Q3 vs. Q2'09Sales and EBIT before special items, in million €
• Q3'09 vs. Q2'09: Volumes +8%, prices 0%, portfolio +3%, currencies –2%[Q3'09 vs. Q3'08: Volumes –8%, prices – 6%, portfolio +38%, currencies +1%]
• Q3'09: positive sales and earnings development thanks to improved demand in some customer industries, price/margin containment and cost reduction measures.
• Positive earnings contribution from former Ciba activities before integration costs.• Care Chemicals: record earnings driven by vitamins and surfactants.• Higher volumes and improved margins in Performance Chemicals.• Stabilization in Paper Chemicals.
Dispersion & Pigments+4%
Care Chemicals+9%
PaperChemicals
+15%
Total sales: €2,651 million: +8.5% EBIT before special items
PerformanceChemicals+10%
221
115 12380
286
0
100
200
300
Q32008
Q42008
Q12009
Q22009
Q32009
700663
896
392
Q32008
Q42008
Q12009
Q22009
Q32009
13
Functional Solutions Q3 vs. Q2'09Sales and EBIT before special items, in million €
• Q3'09 vs. Q2'09: Volumes: +9%, prices: +1%, portfolio: 0%, currencies: –2%[Q3'09 vs. Q3'08: Volumes –12%, prices –13%, portfolio 0%, currencies +1%]
• Catalysts: improved sales and earnings in automotive catalysts due to car scrapping programs. Chemical catalysts continue to be weak.
• Construction Chemicals: slight sales growth in all regions except Middle East; earnings up due to higher prices and lower fixed costs.
• Coatings: higher demand for automotive and decorative paints, stable prices and lower fixed costs supported higher margins.
Catalysts+16%
ConstructionChemicals
+1%
Coatings+3%
Total sales: €1,888 million: +7.6% EBIT before special items
117
-103-46
48106
-100
-50
0
50
100
150
Q32008
Q12009
Q22009
Q32009
543
557
788
Q32008
Q42008
Q12009
Q22009
Q32009
14
Agricultural Solutions 1-9'09 vs. 1-9'08Sales and EBIT before special items, in million €
• 1-9'09 vs. 1-9'08: Volumes -3%, prices +6%, portfolio +1%, currencies +3%[Q3'09 vs. Q3'08: Volumes –6%, prices +2%, portfolio +1%, currencies +1%]
• Sales in Q3'09 vs. Q3’08 minus 2% due to adverse weather conditions as well as lower commodity prices (corn and wheat); positive earnings maintained.
• Higher fixed costs related to R&D and intensified marketing and sales activities. • Good start of growing season in South America.• Potential block-buster herbicide Kixor approved in USA.
Fungicides+7%
Insecticides+7%
Herbicides+8%
Total sales: €2,943 million: +7.4%* EBIT before special items
653 732
0
200
400
600
800
1-9'08 1-9'09
1,021
590
1,332
12%
*Sales growth: +3% in constant exchange rates and continued portfolio
15
905622 471 469 467
-200
0
200
400
600
800
1,000
Q32008
Q42008
Q12009
Q22009
Q32009
Oil & Gas Q3'09 vs. Q3'08Sales and EBIT before special items, in million €
• Q3'09 vs. Q3'08: Volumes 3%, prices/currencies –29%, portfolio 1% [Q3'09 vs. Q2'09: Volumes +9%, prices/currencies –12%, portfolio 0%]
• E&P: Sales and earnings decreased due to significantly lower oil price (–38% in €/bbl).• Natural gas production increased by 24%; Yuzhno Russkoye achieved plateau-production;
Oil production dropped due to lower OPEC production quota in Libya.• Natural Gas Trading: increased sales volumes could not compensate for 25% lower
prices. • Q4'09 earnings of Oil & Gas expected to be on the level of Q2 and Q3 2009.
E&P–37%
Gas Trading–15%
Total sales: €2,389 million: –24.9% EBIT before special items
E&PGas Trading
870 964
–35
342
37
725 506 550
254831,498
891
Q32008
Q42008
Q12009
Q22009
Q32009
16
Q32009
Q22009
1,280 1,118
604
(257)
Group corporate costs (54) (56)
Currency results, hedges and other valuation effects
(92) (236)
(78)
107
Special items (96) (55)
(312)
Thereof Styrenics 696
Thereof
Corporate research (81)
Styrenics, fertilizers, other business 43
EBIT before special items (295)
EBIT (391)
Sales
Million €
OtherSales and EBIT
Comments• Higher sales and solid
earnings contribution from Styrenics
• Small gain from hedging
• Higher accruals for BASF option program (BOP) given strong share price increase
1717
1 | Business review2 | Operational excellence at work3 | Outlook
18
Annual earnings contribution in million €
0
500
1,000
1,500
2,000
2,500
2003 2004 2005 2006 2007 2008 2009E 2012E
Sustainable improvement of cost baseEfficiency program NEXT
• New EXellence Targets (NEXT): >500 individual projects to simplify processes, structures and production sites in all regions
• Project timeline:2008 – 2011
• Estimated earnings contribution in 2009:~€300 million
• Targeted earnings contribution by 2012:>€1 billion
Completed restructuring programs NEXT
19
Ciba integration - Increased synergy target of at least €450 million
Synergies roughly equally allocated to
• Corporate functions
• Production
• Marketing & sales
• R&D
• Procurement
Additional synergies are related to corporate functions and procurement
Synergy ramp-upin million €
Synergies in percent of sales (2008: €4.0 billion)
Note: Ciba revenues 2008: CHF5,919 million or €3,986 million
290
100
450
600
100
200
300
400
500
end 2009 end 2010 2011/2012 Steady State
10
New target: at least €450 million
≥5
0
7.5
2.5
12.5
20
Ciba – Increased synergy potential and implementation ahead of schedule
Cost synergies
Net reductionof positions
Non-production siteconsolidation
Communication Q2
CommunicationQ3 Trend
Effective 2009 in million € 40 60
350
≥ 450
11%
> 500
3,800
33
56
Total 3,700
Run rate end of 2010 in million € 300
Total steady state end of 2012 in million €
≥ 400
In % of Ciba revenue 2008 10%
Until end of 2009 350
Non-production site consolidation until end of 2009
25
Total number of non-production sites to be consolidated
36
Production site
consolidation
• 23 sites currently under strategic review, i.e. closure, divestiture or restructuring possible: decision in Q1'10
• 32 production sites planned to be optimized and/or restructured
21
1-9‘2009 2009 2010 – 2012Integration costs 470
457
208
118
131
300
thereof special items
800
720
208
176
336
-
-
150
150
thereof- step-up of inventories- accelerated depreciation
of IT system
- restructuring
Integration costsin million €
Ciba integration costs
22
1 | Business review
2 | Operational excellence at work
3 | Outlook
22
23
The economic recovery remains slow and fragile
• Positive impulses from Asia, especially China and from South America
• Business conditions in U.S. and Europe stabilizing
• Still high uncertainty about sustainability of recovery, structural problems continue to exist e.g. overcapacities
• Risks because of continued lending restrictions by commercial banks, increasing insolvencies and unemployment as well as weakening of US$
• Basic assumptions for entire year 2009– Decline in global gross domestic product (–2.5%), global industrial
production (–9.1%) and global chemical production* (–6.1%)– Average exchange rate of $1.40 per €– Average oil price of $60/bbl
• Continuing
* Without pharma
2424
Q4:• Sales at the level of Q3’ 09. EBIT before special items expected to
come in above Q4’ 08 but below Q3’ 09.
Full year:• We anticipate a significant decline in sales and earnings.• Ciba integration accelerated. Higher integration costs will negatively
impact earnings.• Therefore, BASF is unlikely to reach its goal of earning its cost of
capital in 2009.
Outlook 2009
25